Page 33 - ITPS-6-2
P. 33

INNOSC Theranostics and
            Pharmacological Sciences                                           Residual versus curative antimalarial tests




            Table 2. Medicinal plant used in combinations in the   14
            treatment of malaria in Omu‑Aran, Kwara State              Aqueous
                                                                       Organic
             No  Plants in combinations
                                                                  12
            1   Citrus aurantifolia (leaves and root bark), Lawsonia inermis
            2   Magnifera indica (stem bark), Chromolaena odorata
            3   Chromolaena odorata, Senna siamea, Tithonia diversifolia  10
            4   Azadirachta indica, Carica papaya, Chromolaena odorata
            5   Azadirachta indica, Carica papaya, Nauclea latifolia  8
            6   Tithonia diversifolia, Ocimum basilicium, Chromolaena odorata  Number of extracts
            7   Magnifera indica, Psidium guajava, Chromolaena odorata  6
            8   Magnifera indica (male), Carica papaya (withered leaves),
                Chromolaena odorata
            9   Magnifera indica, Anarcadium occidentale, Chromolaena odorata  4
            10  Magnifera indica, Anarcadium occidentale, Lawsonia inermis
            11  Lawsonia inermis, Magnifera indica, Psidiumguajava
                                                                   2
            12  Anarcadium occidentale, Azardirachta indica, Carica papaya,
                Chromolaena odorata
            13  Magnifera indica, Anarcadium occidentale, Azadirachta indica,   0
                Chromolaena odorata                                     High    Moderate   Weak     No activity
            14  Magnifera indica, Anarcadium occidentale, Azadirachta indica,   Figure 2. The curative antimalarial activity of the selected medicinal plant
                Morinda lucida                                 (aqueous and organic extracts).
            15  Magnifera indica, Anarcadium occidentale, Citrus aurantifolia,
                Lawsonia inermis                               3.2.1.2 N. latifolia
                                                               The curative antimalarial activity of the aqueous and DCM-
            doses administered in the curative tests, one dose exhibited   MeOH (1:1) extracts from both the leaves and stem bark of
            high activity (PCS  >60%), 6 showed moderate activity, 22   N. latifolia was found to be very poor, ranging from weakly
            displayed weak activity, and 13 showed no activity (PCS ≤0)   active (16.51%) to inactive (−56.93%) (Table 4). The mean
            (Figure 2). The dichloromethane-methanol (DCM-MeOH)   survival time (MST) of P. berghei-infected mice treated with
            (1:1) extracts generally displayed greater antiplasmodial   N. latifolia ranged from 6.80 ± 1.09 to 10.20 ± 1.10 days,
            potential compared to the aqueous extracts. Two of the   while the groups treated with chloroquine and the vehicle
            aqueous groups exhibited moderate activity, 12 had weak   had MTS between 13.00 ± 4.55 and 13.75 ± 1.89 days and
            activity, and 13 showed no activity, while 1 DCM-MeOH   7.60 ± 0.55 to 9.80 ± 1.64 days, respectively (Table 4).
            (1:1) dose displayed high activity, 4 showed moderate
            activity, 10 exhibited weak activity, and 6 had no activity   3.2.1.3 T. diversifolia
            (PCS ≤0). However, despite the observed activity, there was   The organic (DCM-MeOH [1:1]) extract of T.  diversifolia
            no significant (P < 0.05) increase in survival days. Notably,   leaves exhibited high activity against established infection,
            most of the chloroquine-treated (positive) groups exhibited   with PCS of 66.13%. The aqueous extract also displayed
            significant survival days (Tables 3-7). The activities elicited   moderate activity at the highest tested dose. However,
            by selected medicinal plants are further elaborated below.  in  the  400  mg/kg  organic  group,  most  of  the mice  died
                                                               before the end of the experiment, making it impossible
            3.2.1.1 M. lucida
                                                               to determine the PCS at this concentration (Table 5). The
            The curative activity of  M.  lucida leaves extracts ranged   MST in the T. diversifolia-treated group ranged from 7.25 ±
            from inactivity (PCS ≤0%) to weak activity (PCS <30%),   0.5 to 13.00 ± 4.24 days. The positive and negative control
            while  the stem bark aqueous and DCM-MeOH (1:1)    groups had MST between 14.00 ± 2.45 to 14.67 ± 1.15 days
            extracts demonstrated moderate activity with PC of   and 7.40 ± 0.55 to 9.50 ± 1.73 days, respectively (Table 5).
            43.45% and 51.14%, respectively, at doses of 100 mg/kg and
            400 mg/kg (Table 3). In terms of survival days, the highest   3.2.1.4 L. inermis
            recorded value among M. lucida-treated infected mice was   L. inermis exhibited curative activity ranging from weak
            10.60 ± 1.95, while positive and negative control groups   to moderate. The DCM-MeOH (1:1) extract at 400  mg/
            had values of 18.20 ± 4.82 and 11.20  ± 2.75, respectively.  kg showed a PCS of 34.79% (Table 6). The activity was


            Volume 6 Issue 2 (2023)                         6                         https://doi.org/10.36922/itps.0300
   28   29   30   31   32   33   34   35   36   37   38